1. Introduction Zepbound is a groundbreaking prescription medication recently approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with obesity or overweight-related conditions. Developed by Eli Lilly, Zepbound contains tirzepatide, a dual GIP and GLP-1 receptor agonist previously approved under the bra